Abstract
A patient with advanced breast cancer developed acute kidney injury and generalized renal tubular dysfunction manifested as Fanconi syndrome and distal renal tubular acidosis after treatment with palbociclib, a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor. A kidney biopsy showed acute tubular injury characterized by dilated tubular lumens, flattened epithelium, and loss of brush borders, with no significant interstitial fibrosis. This case illustrates the importance of close and long-term follow-up of kidney function and electrolyte levels after the initiation of a CDK4/6 inhibitor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
